aripiprazole has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Meng, Z; Yang, L; Zhang, S; Zhang, Y | 1 |
| Bodoukhin, N; Botros, M; Luca, L; Taylor, R | 1 |
| Alba, L; Alonso, L; Coll, C; Ortiz, S; Palma, S; Pérez, H; Sáez, S; Vallés, V | 1 |
3 other study(ies) available for aripiprazole and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Impact of Heat Inactivation of Blood Samples on Therapeutic Drug Monitoring of 5 Second-Generation Antipsychotics and Their Metabolites.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; COVID-19; Drug Monitoring; Hot Temperature; Humans | 2022 |
Joy Journal: A Behavioral Activation Technique Used in the Treatment of Late-Life Depression Associated With Hopelessness During the COVID-19 Pandemic.
Topics: Aged; Antidepressive Agents; Aripiprazole; Cognitive Behavioral Therapy; COVID-19; Depressive Disorder, Major; Female; Fluoxetine; Happiness; Hope; Hospitalization; Humans; SARS-CoV-2; Suicidal Ideation; Unemployment | 2021 |
New-onset psychosis: A case report of brief psychosis related to COVID-19 infection.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; COVID-19; Diazepam; Humans; Male; Psychotic Disorders; SARS-CoV-2; Treatment Outcome | 2021 |